GlassScriptPhysician profile
Timothy B Garner
NPI 1700883881
$772.05
in general payments reported to CMS, 2019-2025
14 companies · $39.47 in 2025
The $39.47 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.84 · 2020: $33.43 · 2021: $21.13 · 2022: $216 · 2023: $111 · 2024: $314 · 2025: $39.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $444 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $444.25 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $136.44 | 2024 | Cd Horizon Spinal System, Graftonand Grafton Plusdemineralized Bone Matrix (Dbm) |
| Abbott Laboratories | $106.14 | 2020-2024 | Proclaim, Eterna |
| Zap Surgical Systems, INC. | $101.65 | 2022 | |
| Arbor Pharmaceuticals, INC. | $100.00 | 2022 | |
| Penumbra, INC. | $96.92 | 2024-2025 | Penumbra System |
| Depuy Synthes Sales INC. | $36.84 | 2019 | |
| Orthofix Medical, INC. | $35.88 | 2021-2022 | |
| Sonex Health, INC. | $32.51 | 2023 | Sx-One Microknife |
| Becton, Dickinson and Company | $31.39 | 2024 | |
| Saluda Medical Americas, INC. | $22.30 | 2023 | Evoke Scs |
| Sanara Medtech INC. | $21.65 | 2024 | Celleraterx |
| Csl Behring | $20.00 | 2023 | Kcentra |
| Nevro Corp. | $16.70 | 2020 | |
| Aesculap, INC. | $13.63 | 2023 | M.Blue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Garner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.